Researchers have developed ShallowBench, a new benchmark designed to evaluate generative AI models used in drug design, specifically focusing on targets with shallow binding pockets. Existing models perform poorly on these challenging targets, which are common in areas like oncology. ShallowBench, comprising 5,780 targets, aims to drive innovation in AI architectures and loss functions to improve drug discovery for historically difficult-to-target proteins. AI
IMPACT Highlights limitations in current generative AI for drug design, spurring development of new models for challenging biological targets.
RANK_REASON The cluster contains a research paper introducing a new benchmark for AI models. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →